Healthcare & Life Sciences News and Articles

Google News – Biopharma External News

Leveraging Synthetic Advisory Boards for Sharper Biopharma Decisions - Pharmaceutical Executive

news.google.com · 12 Sep 2026

Google News – Pharmaceuticals External News

Why Vertex Pharmaceuticals (VRTX) Is Getting Attention Today - simplywall.st

news.google.com · 12 Sep 2026

Google News – FDA (biotech/pharma) External News

After FDA nod for novel Cabometyx formulation, analysts predict limited threat to Exelixis - Fierce Pharma

news.google.com · 12 Sep 2026

Industry News External News

Kanpur murder: 300 calls to contract killer put pharma trader’s son under scanner - The Times of India

news.google.com · 12 Sep 2026

Google News – Pharmaceuticals External News

Kaplan Fox Shareholder Alert: Deadline to Lead in the Securities Fraud Lawsuit Against ARS Pharmaceuticals Inc. (NASDAQ: SPRY) is October 5, 2026 - NewMediaWire

news.google.com · 12 Sep 2026

Google News – Biopharma External News

Helix BioPharma Stock Slides 6.75% as Funding Risk and Clinical Execution Concerns Pressure Sentiment - kalkine.ca

news.google.com · 12 Sep 2026

Google News – Pharmaceuticals External News

Olema Pharmaceuticals (NASDAQ:OLMA) Shares Down 4.4% - Here's Why - MarketBeat

news.google.com · 12 Sep 2026

Google News – Pharmaceuticals External News

12 Health Care Stocks Moving In Friday's Intraday Session - benzinga.com

news.google.com · 12 Sep 2026

Google News – Pharmaceuticals External News

Precision Trading with Ionis Pharmaceuticals Inc. (IONS) Risk Zones - Stock Traders Daily

news.google.com · 12 Sep 2026

Google News – Pharmaceuticals External News

Cosette Pharmaceuticals names Adams as vice president, supply chain and sourcing - ROI-NJ

news.google.com · 12 Sep 2026

Google News – Pharmaceuticals External News

Bragar Eagel & Squire, P.C. Reminds ARS Pharmaceuticals - GlobeNewswire

news.google.com · 12 Sep 2026

Google News – Pharmaceuticals External News

MEDIPAL HOLDINGS CORPORATION and JCR Pharmaceuticals Dose First Patient in Global Phase I/II Trial of JR-446 for Mucopolysaccharidosis Type IIIB - Business Wire

news.google.com · 12 Sep 2026

Google News – Pharmaceuticals External News

Hikma Pharmaceuticals climbs Friday, outperforms market - marketwatch.com

news.google.com · 12 Sep 2026

Google News – Pharmaceuticals External News

Telix Pharmaceuticals (NASDAQ:TLX) Sees Large Volume Increase - Still a Buy? - MarketBeat

news.google.com · 12 Sep 2026

Google News – Pharmaceuticals External News

Jazz Pharmaceuticals Sees Meaningful Long-Term Value From Ziihera's Pursuits Beyond GEA, UBS Says - marketscreener.com

news.google.com · 12 Sep 2026

News & Articles

The Frontline Signal: Turning Daily Friction Into Better Healthcare Hiring

The Digital Health Interpreter: Making Technology Usable in Care

The Pitt is up for 25 Emmys - but the show's biggest fans are real-life doctors

From Roster to Resilience: Building a Workforce Risk Register

The Protocol-to-Workflow Specialist: A Career Emerging in Clinical Research

Jury should decide if university’s hiring process was tainted by diversity goals, court rules

Running costs of vaccine damage scheme more than double amount paid to victims

CMS expands TAVR Medicare coverage to asymptomatic patients

Stryker stock falls on slower peripheral vascular, hip sales

Veterans Affairs taps Amwell for telehealth revamp - Healthcare Dive

8 stories on the healthcare affordability crunch

Campaigners hold vigil as stroke unit closes

Epidural Kit Correction: Medical Action Industries Issues Correction for Epidural Kits Containing Spectra Medical Devices Lidocaine Ampules

UK needs new laws for AI in healthcare, says watchdog

Migraines and acne among five more conditions pharmacists can treat

Maternal Mental Health Policy

4 questions about the FDA’s approach to generative AI

Presidential dialogue on high-threat pathogens

5 takeaways from Oura’s IPO filing

Contractors will bear repair costs for lift defects at Queen Mary Hospital, Hong Kong development chief says

Leveraging Synthetic Advisory Boards for Sharper Biopharma Decisions - Pharmaceutical Executive

Why Vertex Pharmaceuticals (VRTX) Is Getting Attention Today - simplywall.st

After FDA nod for novel Cabometyx formulation, analysts predict limited threat to Exelixis - Fierce Pharma

Kanpur murder: 300 calls to contract killer put pharma trader’s son under scanner - The Times of India

Kaplan Fox Shareholder Alert: Deadline to Lead in the Securities Fraud Lawsuit Against ARS Pharmaceuticals Inc. (NASDAQ: SPRY) is October 5, 2026 - NewMediaWire

Helix BioPharma Stock Slides 6.75% as Funding Risk and Clinical Execution Concerns Pressure Sentiment - kalkine.ca

Olema Pharmaceuticals (NASDAQ:OLMA) Shares Down 4.4% - Here's Why - MarketBeat

12 Health Care Stocks Moving In Friday's Intraday Session - benzinga.com

Precision Trading with Ionis Pharmaceuticals Inc. (IONS) Risk Zones - Stock Traders Daily

Cosette Pharmaceuticals names Adams as vice president, supply chain and sourcing - ROI-NJ

Bragar Eagel & Squire, P.C. Reminds ARS Pharmaceuticals - GlobeNewswire

MEDIPAL HOLDINGS CORPORATION and JCR Pharmaceuticals Dose First Patient in Global Phase I/II Trial of JR-446 for Mucopolysaccharidosis Type IIIB - Business Wire

Hikma Pharmaceuticals climbs Friday, outperforms market - marketwatch.com

Telix Pharmaceuticals (NASDAQ:TLX) Sees Large Volume Increase - Still a Buy? - MarketBeat

Jazz Pharmaceuticals Sees Meaningful Long-Term Value From Ziihera's Pursuits Beyond GEA, UBS Says - marketscreener.com